Deslorelin is a gonadotropin releasing hormone super-agonist (GnRH agonist) also known as an LHRH agonist. It stops the production of sex hormones (testosterone and oestrogen). It is currently approved for use in veterinary medicine and is used to induce ovulation in mares as part of the artificial insemination process. It is also used to stabilize high-risk pregnancies, mainly of livestock. Unlike other GnRH agonists, which are mainly used to inhibit luteinizing hormone and follicle-stimulating hormone by their ultimate downregulation of the pituitary gland.
CAT No: R1948
CAS No: 57773-65-6
Chemical Name: (2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-5-(diaminomethylideneamino)-1-[(2S)-2-(ethylcarbamoyl)pyrrolidin-1-yl]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide
Quick InquiryCustom Peptide SynthesisRegistration of APIs CMC information required for an IND
IND and NDA support Drug master files (DMF) filing
Synonyms/Alias | Deslorelin;57773-65-6;Deslorelina;Desloreline;Somagard;D-Trp LHRH-PEA;Deslorelinum;D-Trp-LHRH-PEA;Bachem 9022;UNII-TKG3I66TVE;TKG3I66TVE;GNRH (D-Trp6,pro9-net);(D-Trp6,Pro9-NHEt)LH-RH;Desloreline [INN-French];Deslorelinum [INN-Latin];Deslorelina [INN-Spanish];(D-Trp6,des-Gly10)-LH-RH ethylamide;(de-Gly10,D-Trp6,Pro-NHEt)-LH-RH;(Des-Gly10(D-Tro6)-LH-RH ethylamide;(D-Trp(sub 6)-pro(sup 9)-NEt)-GNRH;(D-Trp6,des-Gly-NH210)-LH-RH ethylamide;DTXSID2048323;D-Trp(sup 6)-pro(sup 9)-N-ethylamide-LHRH;(D-Trp(sup 6)-pro(sup 9))-LHRH ethylamide;H 4065;Des-Gly-10-Trp-6-ethylamide-LHRH;GnRH, Trp(6)-N-Et-ProNH2(9)-;LHRH, Trp(6)-N-Et-ProNH2(9)-;GnRH, des-Gly(10)-Trp(6)-ethylamide-;LHRH, des-Gly(10)-Trp(6)-ethylamide-;6-Trp-9-N-Et-Pro-10-des-GlyNH2-LHRH;Desloreline (INN-French);Deslorelinum (INN-Latin);Deslorelina (INN-Spanish);DESLORELIN (MART.);DESLORELIN [MART.];LHRH, des-glycyl(10)-tryptophyl(6)-ethylamide-;5-Oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-tryptophyl-L-leucyl-L-arginyl-N-ethyl-L-prolinamide;(D-TRP(SUP 6),DES-GLY(SUP 10))-LH-RH ETHYLAMIDE;LHRH, tryptophyl(6)-N-ethylprolinamide(9)-des-glycinamide(10)-;NCGC00167516-01;Deslorelin [USAN:INN:BAN];Deslorelin?;Deslorellin acetate;LHRH-T;DESLORELIN [MI];DESLORELIN [INN];Deslorelin (USAN/INN);DESLORELIN [USAN];DESLORELIN [WHO-DD];SCHEMBL59413;GTPL9343;CHEMBL2365665;DTXCID0028298;SCHEMBL19409316;BDBM84726;CHEBI:177570;GJKXGJCSJWBJEZ-XRSSZCMZSA-N;MFCD00167401;AKOS015994649;AC-8917;CS-5746;DB11510;HS-2009;NCGC00167516-02;NCGC00167516-03;HY-12556;6-D-phenylalanine-9-(N-ethyl-L-prolinamide)-;D03694;G78019;Q5264591;[des-Gly10, D-Trp6]-LH-RH ethylamide, >=97% (HPLC);6-D-Tryptophan-9-(N-ethyl-L-prolinamide)-1-9-luteinizing hormone-releasing factor (swine);Bachem 9022;D-Trp LHRH-PEA; |
M.F/Formula | C64H83N17O12 |
M.W/Mr. | 1282.4 |
Sequence | One Letter Code:XHWSYWLRP Three Letter Code:H-Pyr-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-NHEt |
Appearance | Solid powder |
Long-term Storage Conditions | Soluble in DMSO, not in water |
InChI | InChI=1S/C64H83N17O12/c1-4-68-62(92)53-16-10-24-81(53)63(93)46(15-9-23-69-64(65)66)74-56(86)47(25-35(2)3)75-58(88)49(27-37-30-70-43-13-7-5-11-41(37)43)77-57(87)48(26-36-17-19-40(83)20-18-36)76-61(91)52(33-82)80-59(89)50(28-38-31-71-44-14-8-6-12-42(38)44)78-60(90)51(29-39-32-67-34-72-39)79-55(85)45-21-22-54(84)73-45/h5-8,11-14,17-20,30-32,34-35,45-53,70-71,82-83H,4,9-10,15-16,21-29,33H2,1-3H3,(H,67,72)(H,68,92)(H,73,84)(H,74,86)(H,75,88)(H,76,91)(H,77,87)(H,78,90)(H,79,85)(H,80,89)(H4,65,66,69)/t45-,46-,47-,48-,49+,50-,51-,52-,53-/m0/s1 |
InChI Key | GJKXGJCSJWBJEZ-XRSSZCMZSA-N |
Canonical SMILES | CCNC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CC5=CNC6=CC=CC=C65)NC(=O)C(CC7=CN=CN7)NC(=O)C8CCC(=O)N8 |
Isomeric SMILES | CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC2=CNC3=CC=CC=C32)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC5=CNC6=CC=CC=C65)NC(=O)[C@H](CC7=CN=CN7)NC(=O)[C@@H]8CCC(=O)N8 |
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us. We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
USA
Address: SUITE 115, 17 Ramsey Road, Shirley, NY 11967, USA
Tel: 1-631-624-4882
Fax: 1-631-614-7828
Email: info@creative-peptides.com
Germany
Address: Industriepark Höchst, Gebäude G830
65929 Frankfurt am Main
Email: info@creative-peptides.com